
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) creates new possibilities via medicine to cure diseases and improve people's lives, and over the past year, marked gains in investors’ portfolios.
Since July 2021, Vertex Pharmaceuticals stock’s one-year return has outperformed several of the world’s most popular tech and consumer discretionary stocks: Tesla Inc. (NASDAQ:TSLA) Apple Inc (NASDAQ:AAPL), Starbucks Corporation (NASDAQ:SBUX), NVIDIA Corporation (NASDAQ:NVDA) and Microsoft Corporation (NASDAQ:MSFT).